Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use    

Global Vaccines Market Research Report

Vaccines and its peer markets - E-Clinical Trial Solutions, Wireless Health, Proteomics, Antibacterials for systemic use, Antivirals for systemic use, Healthcare IT outsourcing, Chromatography Instruments, Chromatography, Immunoassay and 6 other markets - adds up to total Antiinfectives for Systemic Use market.

Vaccines can be segmented by Types, Indications, Geographies, Submarkets and Technologies. Types of this market are Preventive and Therapeutic. Indications of this market are Infectious disease, Cancer and Allergies. Geographies of this market are North America, Europe, Asia-Pacific and Rest of World. Submarkets of this market are Bacterial vaccines, Viral vaccines, Bacterial and viral vaccines, combined, Other vaccines and Animal Vaccines. Technologies of this market are Live Attenuated Vaccines (LAV), Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, Dna Vaccines, Synthetic Vaccines and Dentritic Vaccines.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Vaccines markets are doing well and which are not?
  •  

    What makes our report unique?

    • This reports provides most granular segmentation on Bacterial vaccines, Viral vaccines, Bacterial and viral vaccines, combined and Other vaccines.
    • This report provides market sizing and forecast for the Vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    •  

      Audience for this report

      • Global Vaccines companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
      •  

        Top developments

        • Growing Prevalence Of Animal Diseases Will Result In Employing Preventive Measures Like Vaccines
        • Increasing Incidences Of Zoonotic Diseases In Humans Will Propel The Vaccines Market
        • Increasing Investments By Various Government Agencies, Animal Associations, & Leading Players To Propel
        • Continuous Innovations & Introduction Of New Products Propels The Market
        • Rising Maintenance Costs For Storage Of Vaccines, A Burden On Manufacturers & Distributors
        • Increasing Adoption Of Vegetarian Food In Major Economies Owing To Increasing Risk Of Obesity And Other Chronic Disorders
        • Persistent Economic Slowdown To Affect Growth
show more
PRODUCT TITLE PUBLISHED
Bacterial vaccines Bacterial vaccines
Bacterial vaccines and Viral vaccines, Bacterial...
Upcoming
Viral vaccines Viral vaccines
Viral vaccines and Bacterial vaccines,
Upcoming
Bacterial and viral vaccines, combined Bacterial and viral vaccines, combined
Bacterial and viral vaccines, combined and Bacterial vaccines, Viral...
Upcoming
Global Live Attenuated Vaccines (LAV) Market Global Live Attenuated Vaccines (LAV) Market
The Global Live Attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $2515 million in 2013 and expected to be $3633 million by 2018 at a CAGR of 7.6%. Live Attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Inactivated Vaccines Market Global Inactivated Vaccines Market
The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Sub-unit Vaccines Market Global Sub-unit Vaccines Market
The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Toxoid Vaccines Market Global Toxoid Vaccines Market
The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Conjugate Vaccines Market Global Conjugate Vaccines Market
The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Global Recombinant Vaccines Market Global Recombinant Vaccines Market
The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Dna Vaccines Market Global Dna Vaccines Market
The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Animal Vaccines Animal Vaccines
Animal Vaccines and Bacterial vaccines, Viral vaccines,
Upcoming
Synthetic Vaccines Synthetic Vaccines
Synthetic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Dentritic Vaccines Dentritic Vaccines
Dentritic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Canine Vaccines Canine Vaccines
Canine Vaccines and Feline Vaccines adds up to total Companion animal vaccines market. Canine Vaccines can be segmented by Types, Geographies,...
Upcoming
Feline Vaccines Feline Vaccines
Feline Vaccines and Canine Vaccines adds up to total Companion animal vaccines market. Feline Vaccines can be segmented by Types, Geographies,...
Upcoming
Bovine Vaccines Bovine Vaccines
Bovine Vaccines and Small Ruminant Vaccines adds up to total Livestock market. Bovine Vaccines can be segmented by Types, Geographies,...
Upcoming
Small Ruminant Vaccines Small Ruminant Vaccines
Small Ruminant Vaccines and Bovine Vaccines adds up to total Livestock market. Small Ruminant Vaccines can be segmented by Types, Geographies,...
Upcoming
Infectious Bronchitis Infectious Bronchitis
Infectious Bronchitis and Gumboro Disease, Avian Influenza,
Upcoming
Gumboro Disease Gumboro Disease
Gumboro Disease and Infectious Bronchitis, Avian Influenza,...
Upcoming
Avian Influenza Avian Influenza
Avian Influenza and Infectious Bronchitis, Gumboro Disease,...
Upcoming
55 reports | Show
Connect With Us
US/CAN : +1-888-502-0539